A detailed history of Uni Super Management Pty LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Uni Super Management Pty LTD holds 4,900 shares of EXAS stock, worth $291,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,900
Holding current value
$291,060
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $207,907 - $347,067
4,900 New
4,900 $333,000
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $73,151 - $95,901
1,300 Added 100.0%
2,600 $180 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $81,484 - $123,565
1,300 New
1,300 $122 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Uni Super Management Pty LTD Portfolio

Follow Uni Super Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uni Super Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uni Super Management Pty LTD with notifications on news.